10250 related articles for article (PubMed ID: 10921023)
1. [Rejection of non-immunogenic tumor cells transfected with costimulatory molecule B7 after treatment with IFN-gamma in vitro].
Zheng S; Zhang S; Wang D
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):333-6. PubMed ID: 10921023
[TBL] [Abstract][Full Text] [Related]
2. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
3. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
Tanaka H; Yoshizawa H; Yamaguchi Y; Ito K; Kagamu H; Suzuki E; Gejyo F; Hamada H; Arakawa M
J Immunol; 1999 Mar; 162(6):3574-82. PubMed ID: 10092816
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
[TBL] [Abstract][Full Text] [Related]
5. Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cells.
Ostrand-Rosenberg S; Baskar S; Patterson N; Clements VK
Tissue Antigens; 1996 May; 47(5):414-21. PubMed ID: 8795142
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
Cavallo F; Martin-Fontecha A; Bellone M; Heltai S; Gatti E; Tornaghi P; Freschi M; Forni G; Dellabona P; Casorati G
Eur J Immunol; 1995 May; 25(5):1154-62. PubMed ID: 7539748
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and b7 as costimulators of antitumor immune-responses.
Flores I; Sarkar S; Derosa C; Ozzello L; Nabavi N; Shen Y; Ron Y; Pestka S
Int J Oncol; 1995 Sep; 7(3):501-9. PubMed ID: 21552866
[TBL] [Abstract][Full Text] [Related]
8. Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.
Baskar S; Clements VK; Glimcher LH; Nabavi N; Ostrand-Rosenberg S
J Immunol; 1996 May; 156(10):3821-7. PubMed ID: 8621919
[TBL] [Abstract][Full Text] [Related]
9. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.
Albertini MR; Emler CA; Schell K; Tans KJ; King DM; Sheehy MJ
Cancer Gene Ther; 1996; 3(3):192-201. PubMed ID: 8725884
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
11. [Abrogated or decreased tumorigenicity and metastasis induced by retroviral-mediated B7.1 gene transfer on murine tumors with different immunogenicity].
Ma Q; Wu Y; Yu L
Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):374-7. PubMed ID: 9772496
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells.
Banu N; Meyers CM
Kidney Int; 1999 Jun; 55(6):2250-63. PubMed ID: 10354273
[TBL] [Abstract][Full Text] [Related]
13. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S; Hatzinisiriou I; Ralph SJ
Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
[TBL] [Abstract][Full Text] [Related]
14. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.
Yang G; Hellström KE; Hellström I; Chen L
J Immunol; 1995 Mar; 154(6):2794-800. PubMed ID: 7533183
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice.
Fujii H; Inobe M; Kimura F; Murata J; Murakami M; Onishi Y; Azuma I; Uede T; Saiki I
Int J Cancer; 1996 Apr; 66(2):219-24. PubMed ID: 8603815
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells.
Banu N; Meyers CM
Kidney Int; 1999 Sep; 56(3):985-94. PubMed ID: 10469366
[TBL] [Abstract][Full Text] [Related]
17. Irradiation of singly and doubly transduced murine neuroblastoma cells expressing B7-1 and producing interferon-gamma reduces their capacity to induce systemic immunity.
Katsanis E; Bausero MA; Panoskaltsis-Mortari A; Dancisak BB; Xu Z; Orchard PJ; Davis CG; Blazar BR
Cancer Gene Ther; 1996; 3(2):75-82. PubMed ID: 8729905
[TBL] [Abstract][Full Text] [Related]
18. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
Leong C; Marley J; Loh S; Robinson B; Garlepp M
Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice.
Kaido T; Bandu MT; Maury C; Ferrantini M; Belardelli F; Gresser I
Int J Cancer; 1995 Jan; 60(2):221-9. PubMed ID: 7829220
[TBL] [Abstract][Full Text] [Related]
20. [Phorbol-12-myristate-13-acetate and interferon-gamma synergistic induction of B7-1 expression in ovary carcinoma cells and immunological value].
Zhao X; Wei Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):414-6. PubMed ID: 11360653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
